Ulcer healing · people with leg ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain · pressure ulcer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to complete wound healing ‐ not reported · people with leg ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with leg ulcers
1 finding from 1 review
Health‐related quality of life ‐ not reported · people with leg ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain · people with leg ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in ulcer size · people with leg ulcers
It is very uncertain whether hyaluronic acid changes change in ulcer size (21 days) compared with dextranomer (very low certainty).
1 finding from 1 review
Change in ulcer size · pressure ulcer
It is very uncertain whether platelet‐rich growth factor + hyaluronic acid changes change in ulcer size compared with platelet‐rich growth factor (very low certainty).
1 finding from 1 review
Ulcer healing · people with pressure ulcers
It is very uncertain whether lysine hyaluronate changes complete ulcer healing compared with sodium hyaluronate (very low certainty).
1 finding from 1 review
Time to complete wound healing ‐ not reported · people with pressure ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · people with pressure ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Glaucoma progression at 12 months, measured by additional visual field defects · people with primary angle‐closure suspect
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in IOP measured in mmHg 12 months postintervention · people with primary angle‐closure suspect
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Gonioscopic findings · people with primary angle‐closure suspect
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Need for additional surgery: proportion of participants who received additional surgery to control IOP at 1 year · people with primary angle‐closure suspect
Iridotomy showed no clear difference in need for additional surgery: proportion of participants who received… compared with no iridotomy (low certainty).
1 finding from 1 review
RR 0.5 [0.05, 5.5]
Studies not reported
Low
Mean number of antiglaucoma medications at 1‐year · people with primary angle‐closure suspect
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life measures · people with primary angle‐closure suspect
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with primary angle‐closure suspect
Iridotomy showed no clear difference in adverse events compared with no iridotomy (low certainty).
1 finding from 1 review
RR 13.7 [0.73, 230.42]
Studies not reported
Low
Adherence to iron chelation therapy (%, SD)
1 finding from 1 review
Sustained adherence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found